Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2022-02-14
06:05 am
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		Altium Capital Management LP0
0%		-4,500,000decrease
(Position Closed)		View
2022-02-10
08:17 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		VANGUARD GROUP INC3,326,017
4.36%		1,597,413increase
(+92.41%)		View
2022-01-19
10:48 am
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		Empery Asset Management LP335,745
0.44%		-3,664,255decrease
(-91.61%)		View
2022-01-03
5:57 pm
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		SABBY MANAGEMENT LLC603,812
11%		-4,396,188decrease
(-87.92%)		View
2021-02-24
10:46 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		Altium Capital Management LP4,500,000
5.9%		4,500,000increase
(New Position)		View
2021-02-19
2:45 pm
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		SABBY MANAGEMENT LLC5,000,000
11%		4,416,667increase
(+757.14%)		View
2021-02-18
10:49 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		Empery Asset Management LP4,000,000
5.25%		3,664,255increase
(+1091.38%)		View
2021-02-16
09:59 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		CVI Investments Inc.420,000
1.3%		236,464increase
(+128.84%)		View
2021-02-10
10:57 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		VANGUARD GROUP INC1,728,604
5.96%		1,728,604increase
(New Position)		View
2021-02-09
3:50 pm
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		Hudson Bay Capital Management LP295,880
0.92%		2,232increase
(+0.76%)		View
2021-01-20
11:10 am
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		Empery Asset Management LP335,745
1.05%		-1,664,255decrease
(-83.21%)		View
2021-01-07
1:38 pm
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		SABBY MANAGEMENT LLC583,333
11%		-1,417,087decrease
(-70.84%)		View
2020-12-28
4:57 pm
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		HIRSCHMAN ORIN1,173,230
4%		-826,770decrease
(-41.34%)		View
2020-12-09
06:49 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		HIRSCHMAN ORIN2,000,000
6.9%		2,000,000increase
(New Position)		View
2020-12-02
11:12 am
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		Empery Asset Management LP2,000,000
6.91%		800,000increase
(+66.67%)		View
2020-12-01
8:48 pm
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		SABBY MANAGEMENT LLC2,000,420
11%		2,000,420increase
(New Position)		View
2020-02-14
4:19 pm
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		Anson Funds Management LP181,394
4.9%		-997,021decrease
(-84.61%)		View
2020-02-10
3:16 pm
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		CVI Investments Inc.183,536
5%		-1,204,465decrease
(-86.78%)		View
2020-02-05
3:25 pm
Purchase		13GHepion Pharmaceuticals, Inc.
HEPA		Hudson Bay Capital Management LP293,648
7.84%		293,648increase
(New Position)		View
2019-06-28
08:43 am
Sale		13GHepion Pharmaceuticals, Inc.
HEPA		Anson Funds Management LP359,907
9.9%		-818,508decrease
(-69.46%)		View
Goto 0, 1, Next